Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No Intervention (subjects were previously treated with Onglyza®).
- Who it may be relevant to
- Registry conditions: Rectal Carcinoma. Basic parameters: 18 years — 90 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma : a Retrospective Study
Overview
the study will discuss different pattern of treatment and the outcomes of locally advanced rectal carcinoma as a retrospective study. The study will be conducted at Department of Clinical Oncology, Sohag University Hospital and Sohag Cancer center, Sohag, Egypt. including patients diagnosed and treated between 2018 and 2025. and the data will be collected from reports .
Interventions
- Other No Intervention (subjects were previously treated with Onglyza®)
no intervention
Primary outcome measures
- Estimation of overall survival (OS ). [Time frame: 2018 _ 2025]
- Estimation of Response rate . [Time frame: 2018-2025]
- Estimation of disease-free survival (DFS) . [Time frame: 2018-2025]
Secondary outcome measures (1)
- treatment-related toxicity: (graded by CTCAE v5). [Time frame: 2018-2025]
Eligibility criteria
Inclusion criteria
- patients who were more than18 years old at time of diagnosis.
- Patients with histologically confirmed rectal carcinoma.
- Stage II-III (locally advanced) disease at initial diagnosis.
Exclusion criteria
- Patients with distant metastasis at presentation.
- Patients diagnosed with double malignancy.
- Patients with incomplete medical records.
- Organ failure
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07363863 · Soh-Med--25-11-2MS